Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06455670 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Chinese Medicine on Patients With Severe Acute Exacerbation of COPD

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Aug 31, 2024 to Oct 20, 2024
    • Collaborators revised (7)
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study was to evaluate the effects of Chinese Medicine on patients with severe AECOPD, and to provide a basis for the establishment of integrated CM and Western medicine diagnosis and treatment scheme for patients with severe AECOPD.
Trial Details
NCT Number NCT06455670
Lead Sponsor Henan University of Traditional Chinese Medicine
Collaborators: Peking University Third Hospital, Jiangsu Province Hospital of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenzhen Hospital of Southern Medical University, Qingdao Haici Hospital, Xiangyang Hospital of Traditional Chinese Medicine
Conditions
(from sponsor)		 Acute Exacerbation Of Chronic Obstructive Pulmonary Disease
Enrollment 468 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov